2024 Q1 Form 10-K Financial Statement

#000151597124000035 Filed on April 01, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4 2023
Revenue $5.636M $4.902M $18.22M
YoY Change 39.79% 2.29% -8.99%
Cost Of Revenue $4.508M $4.568M $14.85M
YoY Change 48.8% 62.95% -1.22%
Gross Profit $1.128M $333.5K $3.374M
YoY Change 12.54% -83.23% -32.39%
Gross Profit Margin 20.01% 6.8% 18.51%
Selling, General & Admin $1.766M $2.375M $6.343M
YoY Change 9.79% 2.54% -14.11%
% of Gross Profit 156.62% 712.14% 188.03%
Research & Development $206.1K $138.6K
YoY Change 43.58% -5.33%
% of Gross Profit 18.28% 4.11%
Depreciation & Amortization $2.449K $3.090K $12.35K
YoY Change -20.69% 0.0% 0.0%
% of Gross Profit 0.22% 0.93% 0.37%
Operating Expenses $1.974M $1.888M $6.494M
YoY Change 12.5% -8.95% -13.92%
Operating Profit -$847.0K -$1.555M -$3.121M
YoY Change 12.45% 1722.88% 22.15%
Interest Expense $104.3K -$269.1K $820.3K
YoY Change -35.4% 62.24% 105.56%
% of Operating Profit
Other Income/Expense, Net $9.079M $133.9K -$820.2K
YoY Change -5721.89% -19.91% 106.25%
Pretax Income $8.233M -$1.690M -$3.941M
YoY Change -1000.02% 1911.17% 33.48%
Income Tax $149.4K $0.00
% Of Pretax Income 1.82%
Net Earnings $8.083M -$1.690M -$3.941M
YoY Change -983.69% 1911.17% 33.48%
Net Earnings / Revenue 143.42% -34.48% -21.62%
Basic Earnings Per Share $0.19 -$0.09
Diluted Earnings Per Share $0.19 -$0.04 -$0.09
COMMON SHARES
Basic Shares Outstanding 43.33M shares 42.96M shares 42.77M shares
Diluted Shares Outstanding 43.60M shares 42.77M shares

Balance Sheet

Concept 2024 Q1 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.885M $777.1K $777.1K
YoY Change 143.41% -62.2% -62.2%
Cash & Equivalents $3.885M $777.1K $777.1K
Short-Term Investments
Other Short-Term Assets $1.000M $129.7K
YoY Change 609656.1% 111.25%
Inventory $765.0K $1.230M $1.230M
Prepaid Expenses $118.2K $129.7K
Receivables $1.947M $1.497M $1.497M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $7.715M $3.633M $3.633M
YoY Change 118.9% -12.52% -12.52%
LONG-TERM ASSETS
Property, Plant & Equipment $21.74K $24.18K $24.18K
YoY Change -35.02% -33.81% -33.83%
Goodwill
YoY Change
Intangibles $1.078M
YoY Change -9.29%
Long-Term Investments
YoY Change
Other Assets $74.54K $74.54K $74.54K
YoY Change 0.0% 0.9% 0.89%
Total Long-Term Assets $832.9K $1.176M $1.176M
YoY Change -34.01% -9.4% -9.4%
TOTAL ASSETS
Total Short-Term Assets $7.715M $3.633M $3.633M
Total Long-Term Assets $832.9K $1.176M $1.176M
Total Assets $8.548M $4.810M $4.810M
YoY Change 78.58% -11.78% -11.78%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.636M $3.710M $3.710M
YoY Change 88.33% 175.01% 175.01%
Accrued Expenses $130.1K $127.7K $127.7K
YoY Change 7.87% 7.89% 7.89%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $3.655M $3.655M
YoY Change -100.0% 19.02% 19.02%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.916M $7.493M $7.493M
YoY Change -37.09% 65.1% 65.1%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $297.2K $330.5K $330.5K
YoY Change -30.46% -27.87% -27.87%
Total Long-Term Liabilities $297.2K $330.5K $330.5K
YoY Change -30.46% -27.87% -27.87%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.916M $7.493M $7.493M
Total Long-Term Liabilities $297.2K $330.5K $330.5K
Total Liabilities $3.213M $7.823M $7.823M
YoY Change -36.53% 56.57% 56.57%
SHAREHOLDERS EQUITY
Retained Earnings -$4.156M -$12.24M
YoY Change -54.89% 47.49%
Common Stock $43.33K $43.15K
YoY Change 2.0% 2.14%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $5.335M -$3.013M -$3.013M
YoY Change
Total Liabilities & Shareholders Equity $8.548M $4.810M $4.810M
YoY Change 78.58% -11.78% -11.78%

Cashflow Statement

Concept 2024 Q1 2023 Q4 2023
OPERATING ACTIVITIES
Net Income $8.083M -$1.690M -$3.941M
YoY Change -983.69% 1911.17% 33.48%
Depreciation, Depletion And Amortization $2.449K $3.090K $12.35K
YoY Change -20.69% 0.0% 0.0%
Cash From Operating Activities -$2.787M -$594.5K -$1.792M
YoY Change 456.51% 175.48% -1.64%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $9.559M $0.00 $0.00
YoY Change -100.0% -100.0%
Cash From Investing Activities $9.559M $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$3.664M 49.50K $513.5K
YoY Change -8981.21% 171.23% -82.5%
NET CHANGE
Cash From Operating Activities -$2.787M -594.5K -$1.792M
Cash From Investing Activities $9.559M 0.000
Cash From Financing Activities -$3.664M 49.50K $513.5K
Net Change In Cash $3.108M -545.0K -$1.279M
YoY Change -776.22% 190.58% -213.86%
FREE CASH FLOW
Cash From Operating Activities -$2.787M -$594.5K -$1.792M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0000845819
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
usd
CY2022 ktel Noncompensatory Stock Options Exercised
NoncompensatoryStockOptionsExercised
usd
CY2022 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
usd
CY2023 us-gaap Proceeds From Sale Of Other Productive Assets
ProceedsFromSaleOfOtherProductiveAssets
usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2023 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
usd
CY2023 us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
CY2022 us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
CY2023 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
usd
CY2023 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
shares
CY2022 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
shares
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
pure
CY2023Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2023 us-gaap Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
usd
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
usd
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
001-10171
CY2023 dei Entity Registrant Name
EntityRegistrantName
KonaTel, Inc.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
80-0973608
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
500 N. Central Expressway
CY2023 dei Entity Address Address Line2
EntityAddressAddressLine2
Ste. 202
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Plano
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
75074
CY2023 dei City Area Code
CityAreaCode
214
CY2023 dei Local Phone Number
LocalPhoneNumber
323-8410
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
22153037 usd
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
43333220 shares
CY2023 dei Auditor Name
AuditorName
Haynie & Company
CY2023 dei Auditor Location
AuditorLocation
Salt Lake City, Utah
CY2023 dei Auditor Firm
AuditorFirmId
457
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
777103 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2055634 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1496799 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1510118 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
1229770 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
526337 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
129706 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
61241 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
164 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
3633378 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
4153494 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
24184 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
36536 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
634251 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
634251 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
443328 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
553686 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
74543 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
73883 usd
CY2023Q4 us-gaap Assets
Assets
4809684 usd
CY2022Q4 us-gaap Assets
Assets
5451850 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
3709691 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1348931 usd
CY2023Q4 us-gaap Loans Payable Current
LoansPayableCurrent
3655171 usd
CY2022Q4 us-gaap Loans Payable Current
LoansPayableCurrent
3070947 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
127716 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
118382 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
7492578 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4538260 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
330511 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
458227 usd
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
330511 usd
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
458227 usd
CY2023Q4 us-gaap Liabilities
Liabilities
7823089 usd
CY2022Q4 us-gaap Liabilities
Liabilities
4996487 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
43145720 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
43145720 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
42240406 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
42240406 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
43146 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
42240 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
9182140 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
8710987 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-12238691 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-8297864 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-3013405 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
455363 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4809684 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5451850 usd
CY2023 us-gaap Revenues
Revenues
18223745 usd
CY2022 us-gaap Revenues
Revenues
20023340 usd
CY2023 us-gaap Cost Of Revenue
CostOfRevenue
14850105 usd
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
15033733 usd
CY2023 us-gaap Gross Profit
GrossProfit
3373640 usd
CY2022 us-gaap Gross Profit
GrossProfit
4989607 usd
CY2023 us-gaap Labor And Related Expense
LaborAndRelatedExpense
3995698 usd
CY2022 us-gaap Labor And Related Expense
LaborAndRelatedExpense
4974989 usd
CY2023 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
5804 usd
CY2022 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
8129 usd
CY2023 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
215 usd
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
29133 usd
CY2023 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
1526947 usd
CY2022 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
1509269 usd
CY2023 us-gaap Other General Expense
OtherGeneralExpense
191556 usd
CY2022 us-gaap Other General Expense
OtherGeneralExpense
206380 usd
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
12352 usd
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
12352 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
155734 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
300042 usd
CY2023 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
154533 usd
CY2022 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
106402 usd
CY2023 ktel Application Development Costs
ApplicationDevelopmentCosts
138600 usd
CY2022 ktel Application Development Costs
ApplicationDevelopmentCosts
146400 usd
CY2023 us-gaap Real Estate Taxes And Insurance
RealEstateTaxesAndInsurance
312804 usd
CY2022 us-gaap Real Estate Taxes And Insurance
RealEstateTaxesAndInsurance
251196 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
6494243 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
7544292 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-3120603 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-2554685 usd
CY2023 us-gaap Interest Expense
InterestExpense
820254 usd
CY2022 us-gaap Interest Expense
InterestExpense
399031 usd
CY2023 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
30 usd
CY2022 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
1356 usd
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-820224 usd
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-397675 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-3940827 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-2952360 usd
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.09
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.09
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
42773269 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
41863283 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
42773269 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
41863283 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
2607335 usd
CY2022 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
108250 usd
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
692138 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-2952360 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
455363 usd
CY2023 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
214502 usd
CY2023 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
257557 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-3940827 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-3013405 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-3940827 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-2952360 usd
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
12352 usd
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
12352 usd
CY2023 us-gaap Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
-161474 usd
CY2022 us-gaap Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
-94478 usd
CY2023 us-gaap Provision For Other Losses
ProvisionForOtherLosses
215 usd
CY2022 us-gaap Provision For Other Losses
ProvisionForOtherLosses
29133 usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
257557 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
692138 usd
CY2023 ktel Noncompensatory Stock Options Exercised
NoncompensatoryStockOptionsExercised
123750 usd
CY2023 ktel Change In Right Of Use Asset
ChangeInRightOfUseAsset
-110358 usd
CY2022 ktel Change In Right Of Use Asset
ChangeInRightOfUseAsset
83612 usd
CY2023 ktel Change In Lease Liability
ChangeInLeaseLiability
-118382 usd
CY2022 ktel Change In Lease Liability
ChangeInLeaseLiability
92941 usd
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-13104 usd
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
264564 usd
CY2023 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
703433 usd
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-40502 usd
CY2023 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
68465 usd
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-98640 usd
CY2023 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
2360760 usd
CY2022 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
418483 usd
CY2023 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
495 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1792032 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1821869 usd
CY2022 us-gaap Proceeds From Sale Of Other Productive Assets
ProceedsFromSaleOfOtherProductiveAssets
10000 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
10000 usd
CY2023 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
554750 usd
CY2022 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
3150000 usd
CY2023 us-gaap Payments Of Loan Costs
PaymentsOfLoanCosts
132000 usd
CY2022 us-gaap Payments Of Loan Costs
PaymentsOfLoanCosts
173532 usd
CY2022 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
150000 usd
CY2023 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
90751 usd
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
108250 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
513501 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2934718 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1278531 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1122849 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2055634 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
932785 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
777103 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2055634 usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
419525 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
3099 usd
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
472974 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1496799 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1510118 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
1229770 usd
CY2023Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
0 usd
CY2022Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
0 usd
CY2023 ktel Property And Equipment Depreciation
PropertyAndEquipmentDepreciation
Leasehold improvements are amortized over the lesser of the lease term or estimated useful life, furniture and fixtures, equipment, and vehicles are depreciated over periods ranging from five to seven (5-7) years, and billing software is depreciated over three (3) years which represents the estimated useful life of the assets.
CY2023Q4 ktel Collateral Deposits
CollateralDeposits
0 usd
CY2022Q4 ktel Collateral Deposits
CollateralDeposits
0 usd
CY2023Q4 ktel Operating Lease Assets And Liabilities Recorded
OperatingLeaseAssetsAndLiabilitiesRecorded
151471 usd
CY2023Q4 ktel Operating Lease Assets And Liabilities
OperatingLeaseAssetsAndLiabilities
458227 usd
CY2022Q4 ktel Operating Lease Assets And Liabilities
OperatingLeaseAssetsAndLiabilities
576609 usd
CY2023 us-gaap Revenue Recognition Deferred Revenue
RevenueRecognitionDeferredRevenue
<p id="xdx_84F_eus-gaap--RevenueRecognitionDeferredRevenue_z35c8Rryu8Ul" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Deferred Revenue</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Services for cellular and telecommunication services have a monthly recurring charge that is billed in advance. This charge covers a thirty (30) or thirty-one (31)-day period. This charge is deferred for the period in which it was received and recorded as revenue at the conclusion of this period. Costs, mainly from outside providers, associated with the deferred revenue are recognized in the same period as revenue is recognized.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2023 us-gaap Revenue Recognition Sales Of Services
RevenueRecognitionSalesOfServices
<p id="xdx_840_eus-gaap--RevenueRecognitionSalesOfServices_znVcPFN0RYAl" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i>Cost of Revenue</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Cost of Revenue includes the cost of communication services, equipment and accessories, shipping costs, and agent compensation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i> </i></p>
CY2023 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
154533 usd
CY2022 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
106402 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
553686 usd
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1981926 shares
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-3940827 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-2952360 usd
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
42773269 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
41863283 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
42773269 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
41863283 shares
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.09
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.09
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
24184 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
36536 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
443328 usd
CY2023 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_842_eus-gaap--ConcentrationRiskCreditRisk_zp32CGEj95af" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Concentrations of Credit Risk</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_915_eus-gaap--TradeAccountsReceivableMember_zIB5KxPtzQT7" style="display: none">Trade Account Receivables</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_916_eus-gaap--SalesRevenueNetMember_zzdIRKOJ2hGh" style="display: none">Sales Revenue</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_91C_eus-gaap--CustomerConcentrationRiskMember_zLD9izjGChj1" style="display: none">Customer Concentration</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Financial instruments which potentially subject the Company to concentrations of credit risk consist primarily of receivables, cash, and cash equivalents.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">All cash and cash equivalents and restricted cash and cash equivalents are held at high credit financial institutions. These deposits are generally insured under the FDIC’s deposit insurance coverage; however, from time to time, the deposit levels may exceed FDIC coverage levels.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The Company has a concentration of risk with respect to trade receivables from customers and cellular providers. As of December 31, 2023, the Company had a significant concentration of receivables (defined as customers whose receivable balances are greater than 10% of total receivables) due from two (2) customers in the amounts of $<span id="xdx_90F_eus-gaap--FairValueConcentrationOfRiskAccountsReceivable_iI_c20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--TradeAccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__custom--SpecificCustomerConcentrationAxis__custom--CustomerOneMember_zYG9l6nEWE39" title="Receivables, concentration">1,024,308</span> or <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_dp_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--TradeAccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__custom--SpecificCustomerConcentrationAxis__custom--CustomerOneMember_zSUIfsHeYzB7" title="Concentration risk">68.5</span>% and $<span id="xdx_90B_eus-gaap--FairValueConcentrationOfRiskAccountsReceivable_iI_c20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--TradeAccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__custom--SpecificCustomerConcentrationAxis__custom--CustomerTwoMember_zo8SeQe6ebSa" title="Receivables, concentration">283,536</span> or <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--TradeAccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__custom--SpecificCustomerConcentrationAxis__custom--CustomerTwoMember_zPy7tKX6neff" title="Concentration risk">19.0</span>%. </span><span style="font-family: TimesNewRomanPSMT,serif">It should be noted that the largest customer is the federal government, as administered by USAC, under the authority of the FCC). </span><span style="font-family: Times New Roman, Times, Serif">As of December 31, 2022, the Company had a significant concentration of receivables from two (2) customers in the amounts of $<span id="xdx_90C_eus-gaap--FairValueConcentrationOfRiskAccountsReceivable_iI_c20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--TradeAccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__custom--SpecificCustomerConcentrationAxis__custom--CustomerOneMember_zxSY3u8jQsy5" title="Receivables, concentration">859,334</span> or <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--TradeAccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__custom--SpecificCustomerConcentrationAxis__custom--CustomerOneMember_zo6IWr41W8y3" title="Concentration risk">57.0</span>% and $<span id="xdx_900_eus-gaap--FairValueConcentrationOfRiskAccountsReceivable_iI_c20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--TradeAccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__custom--SpecificCustomerConcentrationAxis__custom--CustomerTwoMember_zPu4ybPgmQ2h" title="Receivables, concentration">255,136</span> or <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--TradeAccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__custom--SpecificCustomerConcentrationAxis__custom--CustomerTwoMember_z1N5MqUEYqm5" title="Concentration risk">16.9</span>%.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2023Q4 us-gaap Inventory Net
InventoryNet
1229770 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
526337 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
461611 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
461611 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
437427 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
425075 usd
CY2023 us-gaap Lessee Operating Lease Description
LesseeOperatingLeaseDescription
the Company had four (4) properties with lease terms in excess of one (1) year. Of these four (4) leases, two (2) leases expire in 2025; one (1) lease expires in 2026; and one (1) lease expires in 2030
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
458227 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
155325 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
129543 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
65967 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
54000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
144000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
548835 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
90608 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
458227 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
127716 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
330511 usd
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P60M12D
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0687 pure
CY2023 us-gaap Operating Lease Expense
OperatingLeaseExpense
145485 usd
CY2023Q4 us-gaap Finite Lived Customer Lists Gross
FiniteLivedCustomerListsGross
1135962 usd
CY2022Q4 us-gaap Finite Lived Customer Lists Gross
FiniteLivedCustomerListsGross
1135962 usd
CY2023Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
2407001 usd
CY2022Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
2407001 usd
CY2023Q4 us-gaap Finite Lived License Agreements Gross
FiniteLivedLicenseAgreementsGross
634251 usd
CY2022Q4 us-gaap Finite Lived License Agreements Gross
FiniteLivedLicenseAgreementsGross
634251 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3542963 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3542963 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
634251 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
634251 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
443328 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
553686 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1077579 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1187937 usd
CY2023 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 usd
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Fair Value Disclosure
FiniteLivedIntangibleAssetsFairValueDisclosure
634251 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Fair Value Disclosure
FiniteLivedIntangibleAssetsFairValueDisclosure
634251 usd
CY2023 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 number
CY2023 us-gaap Revenues
Revenues
18223745 usd
CY2023 us-gaap Gross Profit
GrossProfit
3373640 usd
CY2023 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
12352 usd
CY2023 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
0 usd
CY2022 us-gaap Revenues
Revenues
20023340 usd
CY2022 us-gaap Gross Profit
GrossProfit
4989607 usd
CY2022 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
12352 usd
CY2022 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
0 usd
CY2023 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
257557 usd
CY2022 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
692138 usd
CY2023 us-gaap Deferred Compensation Arrangement With Individual Allocated Share Based Compensation Expense
DeferredCompensationArrangementWithIndividualAllocatedShareBasedCompensationExpense
1771133 usd
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
1.8129 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
1.9271 pure
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0453 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0190 pure
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4405000 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.59
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y2M19D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
2260138 usd
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
3245000 shares
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.86
CY2023 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
950000 shares
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.53
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
700000 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6000000 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.75
CY2023 ktel Weighted Average Remaining Life At End Of Period
WeightedAverageRemainingLifeAtEndOfPeriod
P3Y8M8D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
872463 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
641155 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.50
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P1Y6M29D
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
247547 usd
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4260000 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.37
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y3M
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
5862938 usd
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
900000 shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.16
CY2022 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
625000 shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.17
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
920750 usd
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
130000 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4405000 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.59
CY2022 ktel Weighted Average Remaining Life At End Of Period
WeightedAverageRemainingLifeAtEndOfPeriod
P3Y2M19D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
2260138 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1722041 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.36
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P1Y9M18D
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
1271653 usd
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
1657095 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
850050 usd
CY2023Q4 ktel Deferred Tax Assets Depreciation And Amortization
DeferredTaxAssetsDepreciationAndAmortization
-14128 usd
CY2022Q4 ktel Deferred Tax Assets Depreciation And Amortization
DeferredTaxAssetsDepreciationAndAmortization
3716 usd
CY2023Q4 ktel Deferred Tax Assets Stock Option Expense
DeferredTaxAssetsStockOptionExpense
304978 usd
CY2022Q4 ktel Deferred Tax Assets Stock Option Expense
DeferredTaxAssetsStockOptionExpense
324528 usd
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1947945 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1178294 usd
CY2023 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-850623 usd
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-619996 usd
CY2023 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
850623 usd
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
619996 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
7890930 usd
CY2023Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
7890930 usd
CY2023Q4 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
true
CY2023Q4 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
true
CY2023Q4 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
true
CY2023Q4 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
true

Files In Submission

Name View Source Status
0001515971-24-000035-index-headers.html Edgar Link pending
0001515971-24-000035-index.html Edgar Link pending
0001515971-24-000035.txt Edgar Link pending
0001515971-24-000035-xbrl.zip Edgar Link pending
exhibit311.htm Edgar Link pending
exhibit312.htm Edgar Link pending
exhibit32.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
ktel-20231231.xsd Edgar Link pending
ktel10k123123.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
ktel-20231231_cal.xml Edgar Link unprocessable
ktel-20231231_def.xml Edgar Link unprocessable
ktel-20231231_pre.xml Edgar Link unprocessable
ktel-20231231_lab.xml Edgar Link unprocessable
ktel10k123123_htm.xml Edgar Link completed
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending